August 5, 2021

News Collective

Complete New Zealand News World

Corona virus: New Zealand approves use of Pfizer-Bioentech vaccine

By

Reuters

The 02/03/2021 7:36 AM

Read for 1 minute

The government said on Wednesday that New Zealand’s drug regulator Metsoff had approved the emergency use of the Covit-19 vaccine, developed by US laboratory Pfizer in collaboration with Germany’s Bioendech. / Photo taken on February 1, 2021 / REUTERS / Mike Blake


Mike Blake

WELLINGTON (Reuters) – New Zealand drug regulator Metsoff on Wednesday approved the emergency use of the Kovit-19 vaccine, developed by US laboratory Pfizer in collaboration with Germany’s Bioendech.

Prime Minister Jacinta Artern said in a statement that this was a “positive step” in the fight against the epidemic. “We can now begin preparations for the first phase of our vaccination campaign.”

Officials said vaccines should be given by the end of the first quarter. Before the entire population is vaccinated in the second half of the year, people considered to be at high risk will receive the first dose.

(Praveen Menon; French version by Jean Tersian)

READ  RUGBY A 7 - Fiji Overload New Zealand for Gold Medal!